Latest News

ReActiv8-B Trial 3-Year Patient Outcomes Data Publication in Neuromodulation 

ReActiv8 Neurostimulation Therapy Recommended to be Used in UK’s National Health Service

Mainstay Medical Announces Publication of Three-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™

ReActiv8-B Clinical Trial 2-Year Data Publication

Mainstay Medical Announces Appointment of Jeffrey Dunn and Eric Major to its Board of Directors

Mainstay Announces Limited Commercial Launch of ReActiv8® in the U.S.

The new MainstayMedical.com